Net sales were $1.283 billion for the fourth quarter, compared to $1.794 billion in the prior year's fourth quarter. Selling, ...

The third of four looks at how specific accounting firm niches are being impacted — for good and ill — by artificial ...

Quantum-Si's next-gen protein sequencing tech and growth partnerships show promise, but high costs, financial risks, and ...

During the three months ended December 31, 2024, the Company incurred $4 million of general and administrative expenses ...

Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its fourth quarter and year ended ...

GlobalFoundries is the fifth-largest semiconductor manufacturer in the world. Read why I will remain on the sideline of GFS ...

Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Data From Cohorts 1-3 anticipated to be Presented in MayInitial Results From First Two ...

Clene planning to submit a New Drug Application (NDA) in the second half of 2025 for potential Accelerated Approval of CNM-Au8® in ALSClene planning to initiate the confirmatory Phase 3 RESTORE-ALS tr ...

Rocket Lab USA (NASDAQ: RKLB) was one of the many space stocks that went public by merging with a special purpose acquisition ...

The Educational Choice for Children Act of 2025 would ostensibly provide a tax break on charitable donations to organizations ...

Excluding the unrealized gains in our marketable equity securities portfolio and other ... and providing management and accounting services to third party post-acute operators.